Worldwide Apheresis equipment market revenue is estimated to be valued over US$ 1.7 billion in 2019 and will register a CAGR of 9.8% to create high market opportunity for industry players.
Industry Drivers: The industry is driven by increasing demand for blood supply, rise in geriatric population and growing prevalence of blood disorders. Chronic disease such as cardiovascular diseases is increasing at an alarming rate. As per the estimates, cardiovascular disease is increasing at a rate of 3.8% annually.
To know more, Get Report Sample
By product, the industry revenue is analyzed across devices and accessory kits. Apheresis equipment accounted for 41% of global sales. These devices are further analyzed across automated, semi-automated and others. Automated equipment is gaining prominence with change in healthcare business model. Here, there is no involvement of operator and process based on sensors.
Plasmapheresis is the highest used procedure. The procedure accounted for 53% share in 2018. It is a procedure similar to dialysis that filters blood and removes toxic antibodies. The number of plasmapheresis treatment varies from patients to patients.
Globally, North America apheresis equipment market dominated the global sales. The region accounted for 38.3% of total sales in 2018. The region is bestowed with quality healthcare infrastructure and higher healthcare spending. This in turn, has created favorable ecosystem.
Asia Pacific will register fastest growth and will be at central to future growth. Growth in the region is primarily driven by China and Japan. Improving healthcare amenities and rise in number of chronic cases is boosting overall sales in the region.
To know more, visit https://bekryl.com/industry-trends/apheresis-equipment-market-share-analysis